CRO Vaccine expertise & emerging market access: what’s the value for companies entering into the clinical research arena?

Emerging Markets are key to vaccine development, CRO partners understanding of the challenges involved and knowledge of how to overcome them is key to the success of any trial. Join us on the 11th April to hear from Mark Wood, Associate Director for Proposals & Business Intelligence at Encorium to understand why the range of experience from developing Clinical Developments …

Climate change in vaccine trials: Moving from a one-size-fits-all to a custom fit in operational delivery

Dr Vigdorth has 30 years of drug development research experience in the clinical setting and pharmaceutical and CRO industries. She has led clinical development programs across a range of therapeutic indications with extensive experience in antibiotic, antiviral, vaccine, and antifungal agents.   Dr Vigdorth's experience has developed from multiple perspectives including working in the clinical investigative site setting, multi- national …